eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
7.80
-0.82 (-9.51%)
At close: Jun 9, 2026, 4:00 PM EDT
8.30
+0.50 (6.41%)
After-hours: Jun 9, 2026, 6:48 PM EDT
eXoZymes Market Cap
eXoZymes has a market cap or net worth of $66.14 million as of June 9, 2026. Its market cap has decreased by -41.58% in one year.
Market Cap
66.14M
Enterprise Value
65.86M
1-Year Change
-41.58%
Ranking
Category
Stock Price
$7.80
Market Cap Chart
Since November 13, 2024, eXoZymes's market cap has decreased from $70.30M to $66.14M, a decrease of -5.93%. That is a compound annual growth rate of -3.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 73.09M | -20.05% |
| Dec 31, 2025 | 91.42M | -41.85% |
| Dec 31, 2024 | 157.23M | 123.64% |
| Nov 13, 2024 | 70.30M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atara Biotherapeutics | 81.97M |
| Lixte Biotechnology Holdings | 80.51M |
| OS Therapies | 79.95M |
| Champions Oncology | 79.90M |
| MAIA Biotechnology | 79.65M |
| Annovis Bio | 78.28M |
| NeurAxis | 78.12M |
| Aardvark Therapeutics | 78.10M |